Page last updated: 2024-09-03

cholestyramine resin and Hypercholesterolemia

cholestyramine resin has been researched along with Hypercholesterolemia in 360 studies

Research

Studies (360)

TimeframeStudies, this research(%)All Research%
pre-1990216 (60.00)18.7374
1990's112 (31.11)18.2507
2000's25 (6.94)29.6817
2010's5 (1.39)24.3611
2020's2 (0.56)2.80

Authors

AuthorsStudies
Hernán, MA; Madenci, AL; Murray, EJ; Wanis, KN1
Alder, M; Bavishi, A; Peterson, J; Stone, NJ; Zumpf, K1
Adewole, EK; Dada, AO; Farombi, EO; Mokobia, OE; Nwichi, SO; Ogidiama, O1
Anzivino, C; Bertolotti, M; Carulli, L; Carulli, N; Corna, F; Del Puppo, M; Gabbi, C; Kienle, MG; Loria, P; Pellegrini, E; Ricchi, M; Zambianchi, L1
Achem, J; Adaramoye, OA; Akintayo, O; Fafunso, MA1
Chapman, MH; Chiu, MC; Kahlon, TS1
Jokubaitis, LA2
Cipollone, F; Faggin, E; Ganassin, L; Grego, F; Mezzetti, A; Pauletto, P; Plebani, M; Puato, M; Rattazzi, M; Zambon, A1
Gupta, A; Guyomard, V; Myint, PK; Rehman, HU; Zaman, MJ1
Gasbarrini, A; Gasbarrini, G; Pizzoferrato, M; Ponziani, FR; Scaldaferri, F1
Aoki, I; Bakalova, R; Hadjidekov, G; Ishii, I; Kitada, M; Saga, T; Tomizawa, A; Zhelev, Z1
Gylling, H; Miettinen, TA1
Dick, JB; Patterson, D; Struthers, AD1
Gylling, H; Miettinen, TA; Vanhanen, H1
Coello-Ramírez, P; González-Ortiz, M; Larrosa-Haro, A; Sáenz-Rivera, C; Vázquez-Camacho, G1
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M1
Nagai, Y; Yamashita, S1
CRAMPTON, RS; HASHIM, SA; TENNENT, DM; VAN ITALLIE, TB1
TENNENT, DM; ZANETTI, ME1
DATTA, DV; SHERLOCK, S1
GHERONDACHE, CN; PINCUS, G1
HASHIM, SA; VANITALLIE, TB1
KLION, FM; LATUFF, AJ; SCHAFFNER, F1
Kane, JP; Malloy, MJ; Pullinger, CR1
Borghi, C; Dormi, A; Gaddi, A; Sangiorgi, Z; Veronesi, M1
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM1
Charlotte, N; Sani, M1
Ballantyne, CM; Chitra, R; Miller, E1
Plans-Rubió, P1
Egashira, Y; Hayakawa, K; Sanada, H; Shibata, S1
Achem, J; Adaramoye, OA; Akintayo, OO; Fafunso, MA1
Cai, Z; Kuroki, M; Pearl, J; Tian, J1
Casdorph, HR3
Vachon, JM1
Bateson, MC1
Schwartz, MZ1
Kostner, G; Lithell, H; Thomis, J; Vessby, B1
Miettinen, TA7
Alberts, AW; Chao, Y; Yamin, TT1
Spengel, FA; Thompson, GR1
Alberts, AW; Chao, YS; Yamin, TT1
Stamler, J1
Aldrich, RF; Battaglini, JW; Brensike, JF; Epstein, SE; Kelsey, SF; Levy, RI; Loh, IK; Passamani, ER; Richardson, JM; Stone, NJ1
Kolata, G1
Rifkind, BM3
Oliver, MF1
Janus, ED; Nye, ER; Scott, PJ1
Nestel, PJ1
Lacombe, C; Nibbelink, M1
Glueck, CJ1
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A1
Johnstone, JR1
Katan, MB1
Canzler, H1
Faruqui, AM; Thurmond, MS; Wenger, J; Wenger, NK1
Kane, JP; Malloy, MJ2
Fears, R; Ferres, H; Richards, DH1
Boyden, TW; Totman, L1
Bard, JM; Dallongeville, J; Duriez, P; Fruchart, JC; Hagen, E; Ose, L; Pfister, P2
Jacob, BG; Richter, WO; Schwandt, P1
Banga, JD; Jacotot, B; Peters, TK; Waite, R1
Bergmann, SD; Haggerty, BJ; Winick, AG; Zavoral, JH1
Peters, TK1
Bergstrand, L; Elinder, LS; Erikson, U; Holme, I; Johansson, J; Mölgaard, J; Nilsson, S; Olsson, AG; Walldius, G1
Elinder, LS; Hådell, K; Holme, I; Johansson, J; Mølgaard, J; Olsson, AG; Walldius, G1
Ginsberg, HN1
Brazg, R; Maciejko, JJ; Patil, S; Rubenfire, M; Shah, A1
Anderson, TJ; Frei, B; Ganz, P; Meredith, IT; Selwyn, AP; Yeung, AC1
Denke, MA1
Denke, MA; Grundy, SM1
Wennmalm, A1
Chin, JP; Dart, AM1
Cigolini, M; Graziani, MS; Grigolini, L; Muggeo, M; Sartori, A; Travia, D; Trimeloni, S; Zenti, MG1
Almon, L; Fletcher, BJ; Fletcher, GF; Staggers, J; Whitner, JT1
Gordon, MO; Schechtman, KB1
Bard, JM; Bodd, E; Borge, M; Eriksen, HM; Fruchart, JC; Hagen, E; Istad, H; Ose, L; Selvig, V; Wolf, MC1
Bergstrand, L; Erikson, U; Hådell, K; Johansson, J; Kaijser, L; Lassvik, C; Mölgaard, J; Nilsson, S; Olsson, AG; Walldius, G1
Rosenberg, R1
Garg, A; Grundy, SM1
Abrams, J; Allen, JW; Chrysant, SG; Fischer, JJ; Ginsberg, H; Johnson, BF; Jokubaitis, L; Keane, WF; Sprecher, DL; Theroux, P1
Lau, CP; Leung, WH; Wong, CK1
Abolafia, JM; Davis, CE; Jenner, JL; Lamon-Fava, S; Levy, RI; Lippel, K; McNamara, JR; Ordovas, JM; Schaefer, EJ1
Kolesár, P1
Hwang, DS; Jokubaitis, LA; Robinson, WT; Smith, HT; Troendle, AJ1
McKenney, JM1
Davidson, C; Davidson, D; Iversen, SA1
Erkelens, DW; Portincasa, P; Renooij, W; Smit, JW; Van Berge-Henegouwen, GP; Van Erpecum, KJ1
Hahn, C; Reichel, C; von Bergmann, K1
Grundy, SM; Vega, GL1
Daggy, BP; Dietschy, JM; Turley, SD1
Gibaldi, M; Kradjan, W1
Richter, WO1
Aranda, JL; del Palacio, A; Jover, E; Nogués, X; Rubiés-Prat, J1
Kamata, K; Kasuya, Y; Suenaga, H; Sugiura, M1
Dotti, MT; Federico, A; Lindenthal, B; Lütjohann, D; Simatupang, A; von Bergmann, K1
Aznar Lucea, J; Blesa Baviera, LC; Dalmau Serra, J; Martínez Silvestre, M; Vayá Montaña, A1
Cullen-Dean, G; Helden, E; McCrindle, BW; O'Neill, MB1
Farmer, JA; Gotto, AM1
Hidaka, H; Kashiwagi, A; Kawabata, T; Kikkawa, R; Kojima, H; Konaka, K; Nakamura, T; Shigeta, Y1
Corrigan, F1
Carrilho, AJ; Medina, WL; Nakandakare, ER; Quintão, EC1
Ito, MK; Shabetai, R1
Kesten, S; Maurer, J; Mayne, L; Scavuzzo, M1
Collins, SM; Gaw, A; Lindsay, GM; Lorimer, AR; Packard, CJ; Shepherd, J1
Celermajer, DS; Simons, J; Simons, LA; Sullivan, D1
Eriksson, M; Hådell, K; Holme, I; Kjellström, T; Walldius, G1
Simons, LA1
Goldberg, DJ; Nicolosi, RJ; Rogers, EJ; Sacchiero, R; Wilson, TA1
Scheen, AJ1
Gordon, BR; Saal, SD1
Oster, G; Thompson, D1
Hjalte, K; Lindgren, B; Persson, U1
Gonzalez, ER1
Benesch, L; Bestehorn, HP; Betz, P; Blümchen, G; Böcker, JF; Braunagel, K; Claus, J; Kappenberger, L; Kiefer, H; Leimenstoll, B; Mathes, P; Meister, G; Neiss, A; Peters, K; Petersen, J; Rensing, UF; Roskamm, H; Samek, L; Schemeitat, K; Schuon, J; Spinder, M; Stiepel, E; Wieland, H1
Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W1
Barter, PJ; O'Brien, RC1
Calara, F; de Nigris, F; Napoli, C; Palinski, W; Witztum, JL1
Chin-Dusting, JP; Shaw, JA1
Abe, M; Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Matsumoto, T; Sugihara, T1
Brown, WV1
Casanada, F; Condorelli, M; D'Armiento, FP; de Nigris, F; Napoli, C; Palinski, W; Silvestre, M; Witztum, JL1
Steinmetz, KL1
Bersohn, I; Dinner, M; Heimann, KW; Mieny, C; Pettifor, J; Saaron, I; Spitz, L; Stein, EA1
Farah, JR; Kwiterovich, PO; Neill, CA2
Lloyd, JK; West, R1
Brannan, PG; Brown, MS; Goldstein, JL1
Lloyd, JK1
Harry, DS; McIntyre, N; Pearson, AJ1
Rider, AK1
Carlson, LA; Olsson, AG; Orö, L; Rössner, S3
Blum, CB; Havlik, RJ; Morganroth, J1
Fisher, WR; Truitt, DH1
Simons, LA; Williams, PF1
Einarsson, K; Hellström, K1
Harding, PA; Mann, JI; Turner, RC; Wilkinson, RH1
Dairou, F; Olsson, AG1
Lempinen, M; Miettinen, TA1
Lloyd, JK; West, RJ2
Grundy, SM3
Dijkhuis-Stoffelsma, R; Fernandes, J; Grose, WF1
Lehtonen, A; Viikari, J1
Diament, J; Forti, N; Giannini, SD1
Howard, AN1
Martz, BL1
Kissebah, AH1
MacSween, RN; Mills, PR; Rooney, PJ; Watkinson, G1
Castrillo, JM; Díaz-Curiel, M; Rapado, A1
Roncari, DA1
Campanari, JC; Forti, NA; Giannini, SD; Timoner, M1
Hagihira, H; Kashu, T; Nakabou, Y; Takano, Y1
Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsick, F1
Cocuzza, E; Conti, F; De Simone, R; Lovati, MR; Sirtori, CR; Sirtori, M1
Jacotot, B1
Blanckaert, D; Farriaux, JP1
Burns, MJ; Hoff, EJ; Smith, EF1
Fallat, RW; Glueck, CJ; Mellies, M; Tsang, RC1
Adams, PW; Moutafis, CD; Myant, NB; Simons, LA; Wynn, V1
Kim, DN; Lee, KT; Li, JR; Reiner, JM; Rogers, DH; Thomas, WA1
Albertini, F1
Fallat, RW; Glueck, CJ; Mellies, MJ; Tsang, RC1
Huttunen, J1
Brunner, G1
Hanson, RF; Isenberg, JN; Page, AR; Sharp, HL; Williams, GC; Zavoral, J1
Lanner, A; Miettinen, TA; Nikkila, EA1
Fosbrooke, AS; Lloyd, JK; West, RJ1
Pain, RW1
Bassett, DR; Hough, JC1
Tierney, E1
Kim, DN; Lee, KT; Reiner, JM; Thomas, WA2
Rossini, L1
Ebeling, T; Happonen, P; Miettinen, TA; Pyörälä, K; Turtola, H; Uusitupa, MI; Voutilainen, E1
Granegger, S; O'Grady, J; Pesau, B; Pirich, C; Schmid, P; Sinzinger, H; Virgolini, I1
Clifton, P; Janus, ED; Nestel, PJ; Parfitt, A; Simons, J; Simons, LA1
Alessandri, C; Peverini, F1
Ose, L1
Jacob, BG; Möhrle, W; Richter, WO; Schwandt, P1
Freedman, LS; Graubard, BI; Schatzkin, A1
Hibbard, DM; Hoogwerf, BJ; Hunninghake, DB1
Aviram, M; Brook, GJ; Hoffman, R1
Ebeling, T; Pyörälä, K; Reijonen, T; Turtola, H; Uusitupa, M; Voutilainen, E1
Caslake, MJ; Gaw, A; Griffin, BA; Packard, CJ; Shepherd, J; Yip, B1
Ebeling, T; Happonen, P; Parviainen, M; Pyörälä, K; Turtola, H; Uusitupa, M; Voutilainen, E1
Courtney, SP; Wightman, JA1
Lundh, BL; Mölgaard, J; Olsson, AG; von Schenck, H1
Bobbio, M; Brusca, A1
Gallagher, JJ; Maher, VM; Myant, NB; Thompson, GR1
Liu, K1
Dammann, HG; Ditschuneit, H; Ditschuneit, HH; Dreyer, M1
Kuijpens, JL; Martens, LL; Rutten, FF; Winter, J1
Bertomeu, A; Casals, E; Cusó, E; Ros, E; Sanllehy, C; Zambón, D1
Insull, W; Marquis, NR; Tsianco, MC1
Ito, MK; Morreale, AP1
Ansoleaga, J; Joven, J; Masana, L; Vilella, E1
Howard, PA1
Bo, M; Fabris, F; Fiandra, U; Pedrazzini, V; Pernigotti, L; Poli, L; Zanocchi, M1
Bard, JM; Douste-Blazy, P; Fruchart, JC; Parra, HJ1
Maher, VM; Thompson, GR1
Brescia, D; DeVault, AR; Ivashkiv, E; Pan, HY; Swites, BJ; Whigan, D; Willard, DA1
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK1
Bimmermann, A; Schleicher, J; Schwartzkopff, W1
Acosta, AM; Arteaga, A; Maíz, A; Velasco, N; Villanueva, CL1
Ast, M; Frishman, WH1
Shapiro, DR; Walker, JF1
Bergmann, S; Fischer, S; Fücker, K; Gehrisch, S; Hanefeld, M; Jaross, W; Lang, PD; Leonhardt, W1
Clifton, P; Cooper, ME; Jennings, GL; Jerums, G; Nestel, PJ; O'Brien, RC; Simons, LA; Sullivan, D1
Belamarich, PF; Deckelbaum, RJ; Dobrin, BE; Salen, G; Starc, TJ; Tint, GS1
Chistiakova, AM; Frolova, IuV; Khanefel'd, M; Leonkhardt, V; Lozovskiĭ, VT; Remezova, OV; Ryzhenkov, VE; Solov'eva, MA; Triufanov, VF; Vasil'eva, LE1
Laupacis, A; Roberts, RS; Sackett, DL1
Diamond, JR; Hanchak, NA; Karnovsky, MJ; McCarter, MD1
Cattin, L; Da Col, PG; Fonda, M; Mazzone, C; Pertot, P1
Carlson, LA; Nilsson, J; Regnström, J; Walldius, G1
Imaizumi, K; Lu, YF; Murakami, J; Sugano, M1
Day, CE1
Kreisberg, R; Mantell, G; Miller, V; Shapiro, DR; Stein, E; Washington, L1
Mölgaard, J; Olsson, AG; von Schenck, H1
Breslow, JL; Eisenberg, S; Weintraub, MS1
Stoy, DB1
Caslake, MJ; Cruickshank, A; Demant, T; Kilday, C; Lorimer, AR; Packard, CJ; Series, JJ; Shepherd, J1
Lintott, CJ; Nye, ER; Robertson, MC; Scott, RS; Sutherland, WH1
Nordøy, A; Ytre-Arne, K1
Rywik, S1
Gohlke, H1
Deslypere, JP1
Turpin, G1
Goldstein, MR1
Swindell, AC; Valentine, JJ1
Brensike, J; Detre, KM; Kelsey, SF; Krauss, RM; Levy, RI; Lindgren, FT; Vranizan, K; Williams, PT1
Mol, MJ; Stalenhoef, AF; Stuyt, PM1
Greten, H; Windler, E1
Anding, RH; Lueg, MC1
Epstein, AM; Oster, G1
Eisenberg, JM; Kinosian, BP1
Carlson, LA; Erikson, U; Johansson, J; Kaijser, L; Lassvik, C; Mölgaard, J; Nilsson, S; Olsson, AG; Stenport, G; Walldius, G1
Tyroler, HA1
Holler, HD; Lang, PD; Müller, S; Steinhagen-Thiessen, E1
Ekelund, LG; Gordon, DJ; Hannan, PJ; Hyde, J; Jacobs, DR; Trost, DC; Whaley, FS1
Duane, WC; Freeman, ML; Gebhard, RL; Hunninghake, DB; Prigge, WF1
Bruno, M; Di Perri, T; Franchi, M1
Bell, SM; Tishler, PV; Winston, SH1
Nikkilä, EA; Tikkanen, MJ1
Havel, RJ; Kane, JP1
Davis, CE; Glueck, CJ; Gordon, DJ; Nelson, JJ; Tyroler, HA1
Gordon, DJ; Knoke, J; Probstfield, JL; Superko, R; Tyroler, HA1
Crouse, JR1
Bailey, KR; Brewer, HB; Hoeg, JM; Maher, MB1
Stuyt, PM1
Widhalm, K1
Donkerlo, TW1
DiPalma, JR1
Corraze, G; Lacombe, C; Nibbelink, M1
Bonfiglioli, D; Branchi, A; Cabrini, E; Pogliaghi, I; Sommariva, D; Tirrito, M1
Kronmal, RA1
Pollak, OJ1
Gotto, AM1
Pepper, GA1
Hackley, JJ; Hassan, AS; Johnson, LL1
Beynen, AC; De Bruijne, JJ; Katan, MB1
Ducimetière, P1
Chase, HP; Porter, KA; Putnam, CW; Starzl, TE1
Levy, RI; Mitchell, S1
Billimoria, JD; Fahmy, MF; Jepson, EM; Maclagan, NF; Torrens, PE1
Bricker, LA1
Khachadurian, AK; Uthman, SM1
Hrubá, F; Pechar, J; Válek, J1
Balfour, JF; Kim, R1
Kuo, PT1
Bersohn, I; Mendelsohn, D; Stein, EA1
Fallat, RW; Glueck, CJ; Scheel, D; Tsang, RC1
Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R1
Fallat, RW; Glueck, CJ; Tsang, R1
Gotto, AM; Levy, RI; McMahon, AE; Morganroth, J1
Albrink, MJ2
Fallat, RW; Glueck, CJ; Mellies, M; Tsang, R1
Bybee, DE; Hamilton, RD1
Fallat, RW; Glueck, CJ; Tsang, RC1
Jain, A; Ryan, JR1
Edwards, IR; Frenk, E; Walker, AE1
Beaumont, JL; Beaumont, V; Buxtorf, JC; Jacotot, B; Le Parco, JC1
Berkowitz, D1
Bilheimer, DW; Brown, WV; Fredrickson, DS; Glueck, CJ; Gotto, AM; Herbert, PN; Kwiterovich, PO; Langer, T; LaRosa, J; Levy, RI; Lux, SE; Rider, AK; Shulman, RS; Sloan, HR; Stone, NJ1
Bagdade, JD1
Evans, RJ; Howard, AN; Hyams, DE2
Danzinger, RG; Hofmann, AF1
Evans, C; Howard, AN; Hyams, DE1
Fumagalli, R; Paoletti, R; Sirtori, R1
Bavina, MV; Koropova, GI; Lobova, NM; Perova, NV1
Faergeman, O1
Connor, WE1
Parker, F; Short, JM1
Howard, AN; Hyams, DE1
Langer, T; Levy, RI1
Gresham, GA; Howard, AN1
Butts, WH; Scott, HW; Younger, RK1
Butts, WH; Scott, HW; Shepard, GH; Younger, RK1
Likoff, W1
Ahrens, EH; Grundy, SM; Nestel, PJ; Salen, G; Schreibman, PH1
Kaffarnik, H; Schneider, J2
Spector, AA1
Weizel, A1
Garcia, MJ; Kannel, WB; McNamara, PM; Pearson, G1
Lewis, B1
Myant, NB1
Ostrander, LD1
Moutafis, CD; Myant, NB1
Pometta, D1
Adamson, G; Strisower, B; Strisower, EH1
Maha, GE1
Rowe, GG1
Buckwald, H; Frantz, ID; Lee, GB; Moore, RB; Varco, RL1
Crane, CA; Frantz, ID; Moore, RB1
Sanbar, SS; Smet, G1
Fallon, HJ; Woods, JW1
Kahlke, W; Schlierf, G1
Hamlin, JT1
Barrillon, A; Binet, JP; de Gennes, JL; Hazan, E; Lenègre, J1
Fredrickson, DS1
Roe, DA1

Reviews

50 review(s) available for cholestyramine resin and Hypercholesterolemia

ArticleYear
A Meta-Analysis Assessing Additional LDL-C Reduction from Addition of a Bile Acid Sequestrant to Statin Therapy.
    The American journal of medicine, 2020, Volume: 133, Issue:11

    Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome

2020
Systematic review on evidence of the effectiveness of cholesterol-lowering drugs.
    Advances in therapy, 2010, Volume: 27, Issue:6

    Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Drug Therapy, Combination; Evidence-Based Practice; Ezetimibe; Fatty Acids, Omega-3; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Patient Selection; Phytosterols; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Treatment Outcome

2010
Use and indications of cholestyramine and bile acid sequestrants.
    Internal and emergency medicine, 2013, Volume: 8, Issue:3

    Topics: Anticholesteremic Agents; Bile; Cholestasis; Cholestyramine Resin; Humans; Hypercholesterolemia; Sequestering Agents

2013
[Combination therapy of hypercholesterolemia].
    Duodecim; laaketieteellinen aikakauskirja, 2002, Volume: 118, Issue:19

    Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Margarine; Phytosterols

2002
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6

    Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome

2003
[Treatment of high blood cholesterol in patients with coronary heart disease].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4

    Topics: Anion Exchange Resins; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Primary Prevention; Probucol; Receptors, LDL; Risk Factors

2003
Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
    Expert review of cardiovascular therapy, 2003, Volume: 1, Issue:1

    Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Diet, Fat-Restricted; Ezetimibe; Genetic Predisposition to Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Receptors, LDL

2003
Effects of hypolipidemic drugs on bile acid metabolism in man.
    Advances in lipid research, 1981, Volume: 18

    Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Plants, Medicinal; Sterols; Thyroxine

1981
Receptor-mediated low-density lipoprotein catabolism.
    Klinische Wochenschrift, 1982, Apr-01, Volume: 60, Issue:7

    Topics: Cholestyramine Resin; Fibroblasts; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Lipoproteins, LDL; Receptors, Cell Surface; Receptors, LDL

1982
Relationship of hypercholesterolemia in rabbits to lipoprotein binding receptors on liver membranes.
    Nutrition reviews, 1983, Volume: 41, Issue:6

    Topics: Animals; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Liver; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein

1983
Treatment of hypercholesterolemia.
    The Medical clinics of North America, 1982, Volume: 66, Issue:2

    Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine

1982
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
    Clinical cardiology, 1995, Volume: 18, Issue:6

    Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin

1995
Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia.
    Blood pressure, 1994, Volume: 3, Issue:5

    Topics: Animals; Arteriosclerosis; Blood Vessels; Cardiovascular Physiological Phenomena; Cholestyramine Resin; Endothelium, Vascular; Humans; Hypercholesterolemia; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits; Vasodilation; Vasodilator Agents

1994
Treating elevated cholesterol levels: the great Satan in perspective.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:3

    Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Health Policy; Humans; Hypercholesterolemia; Risk Factors; United States

1996
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1996, Volume: 77A

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1996
Choosing the right lipid-regulating agent. A guide to selection.
    Drugs, 1996, Volume: 52, Issue:5

    Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides

1996
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
    PharmacoEconomics, 1992, Volume: 2, Issue:1

    Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome

1992
The pharmacoeconomic benefits of cholesterol reduction.
    The American journal of managed care, 1998, Volume: 4, Issue:2

    Topics: Cholestyramine Resin; Coronary Disease; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Health Care Costs; Hospitalization; Humans; Hypercholesterolemia; Risk Factors; United States

1998
Lipids and atherosclerosis: clinical management of hypercholesterolaemia.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:3

    Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Niacin; Nutritional Physiological Phenomena; Probucol

2001
Therapies on the horizon for cholesterol reduction.
    Clinical cardiology, 2001, Volume: 24, Issue:8 Suppl

    Topics: Acetamides; Acetates; Anticholesteremic Agents; Azetidines; Carrier Proteins; Cholestyramine Resin; Ezetimibe; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxysteroid Dehydrogenases; Hypercholesterolemia; Membrane Glycoproteins; Pyrimidines; Rosuvastatin Calcium; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids

2001
Colesevelam hydrochloride.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, May-15, Volume: 59, Issue:10

    Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents

2002
Hyperlipidaemia in children.
    British heart journal, 1975, Volume: 37, Issue:2

    Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholestasis; Cholesterol; Cholestyramine Resin; Chylomicrons; Coronary Disease; Diabetes Complications; Electrophoresis; Fasting; Glycogen Storage Disease; Glycogen Storage Disease Type I; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothyroidism; Infant; Lipoproteins; Liver Diseases; Nephrotic Syndrome; Puberty; Triglycerides; Xanthomatosis

1975
The hypercholesterolaemia of obstructive jaundice.
    Gut, 1975, Volume: 16, Issue:5

    Topics: Animals; Bile Ducts; Cholestasis; Cholesterol; Cholestyramine Resin; Clofibrate; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lipoproteins, VLDL; Liver; Liver Cirrhosis, Biliary; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines; Phospholipids; Plasmapheresis; Protein Binding; Xanthomatosis

1975
The common hyperlipoproteinemias: an understanding of disease mechanisms and their control.
    Annals of internal medicine, 1976, Volume: 85, Issue:4

    Topics: Cholestyramine Resin; Clofibrate; Estrogens; Ethanol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoprotein Lipase; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenotype; Triglycerides

1976
Bile acid metabolism in hyperlipoproteinaemia.
    Clinics in gastroenterology, 1977, Volume: 6, Issue:1

    Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Cholic Acids; Chylomicrons; Clofibrate; Homeostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Triglycerides; Xanthomatosis

1977
Treatment of hypercholesterolemia.
    The American journal of clinical nutrition, 1977, Volume: 30, Issue:6

    Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides

1977
[Therapeutic orientation in the hyperlipidemias].
    Arquivos brasileiros de cardiologia, 1979, Volume: 33, Issue:3

    Topics: Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Sitosterols; Triglycerides

1979
[Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
    Minerva medica, 1992, Volume: 83, Issue:11

    Topics: Adult; Animals; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Pravastatin; Rats; Risk Factors; Simvastatin; Time Factors

1992
[Advance in drug treatment of primary and familial hypercholesterolemia].
    Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1991, Volume: 11, Issue:5

    Topics: Animals; Cholestyramine Resin; Drugs, Chinese Herbal; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Panax; Plants, Medicinal; Probucol

1991
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
    JAMA, 1990, Dec-19, Volume: 264, Issue:23

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity

1990
Bile acid sequestrants.
    Journal of clinical pharmacology, 1990, Volume: 30, Issue:2

    Topics: Chemical Phenomena; Chemistry; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Polyamines; Resins, Plant

1990
[Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases].
    Deutsche medizinische Wochenschrift (1946), 1989, Dec-01, Volume: 114, Issue:50

    Topics: Arteriosclerosis; Cholesterol; Cholestyramine Resin; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Sex Factors

1989
When to treat hyperlipidemia.
    Advances in internal medicine, 1988, Volume: 33

    Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides

1988
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
    Circulation, 1987, Volume: 76, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk

1987
Treatment of hypercholesterolemia.
    Annual review of medicine, 1986, Volume: 37

    Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats

1986
A clinical approach to the hyperlipidemias.
    The Medical clinics of North America, 1971, Volume: 55, Issue:2

    Topics: Aluminum; Carcinoma, Hepatocellular; Cholestasis; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Eye Diseases; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Liver Neoplasms; Myxedema; Nephrotic Syndrome; Nicotinic Acids; Triglycerides; Xanthomatosis

1971
Dietary and drug treatment of primary hyperlipoproteinemia.
    Annals of internal medicine, 1972, Volume: 77, Issue:2

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Phospholipids; Thyroxine; Triglycerides

1972
Hypercholesterolemia and hypertriglyceridemia in children. A pediatric approach to primary atherosclerosis prevention.
    American journal of diseases of children (1960), 1974, Volume: 128, Issue:4

    Topics: Arteriosclerosis; Cardiovascular Diseases; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Economics; Fats; Fatty Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides

1974
Dietary and drug treatment of hyperlipidemia in diabetes.
    Diabetes, 1974, Volume: 23, Issue:11

    Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes Mellitus; Diabetic Angiopathies; Dietary Carbohydrates; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Nicotinic Acids; Thyroxine; Triglycerides

1974
Familial and acquired hyperlipoproteinemias in children and adolescents.
    Postgraduate medicine, 1974, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Blood Protein Disorders; Child; Cholesterol; Cholestyramine Resin; Diet, Atherogenic; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Lipoproteins; Lipoproteins, LDL; Middle Aged; Pedigree; Triglycerides

1974
The primary hyperlipoproteinemias.
    The Journal of the Kentucky Medical Association, 1974, Volume: 72, Issue:12

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, LDL; Nicotinic Acids; Thyroxine; Triglycerides

1974
Therapeutics XIX. Lipid lowering agents.
    The British journal of dermatology, 1972, Volume: 87, Issue:2

    Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins; Metabolic Diseases; Nicotinic Acids; Triglycerides; Xanthomatosis

1972
Treatment of hypercholesterolemia by interference with bile acid metabolism.
    Archives of internal medicine, 1972, Volume: 130, Issue:4

    Topics: Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Hypercholesterolemia; Ileum; Ligation; Liver Circulation; Time Factors

1972
Management of the hyperlipidemic patient.
    The Medical clinics of North America, 1973, Volume: 57, Issue:4

    Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Estrogens; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism, Inborn Errors; Lipids; Metabolism, Inborn Errors; Nicotinic Acids; Triglycerides

1973
Therapy of the hyperlipoproteinemias.
    Acta diabetologica latina, 1972, Volume: 9 Suppl 2

    Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Phenformin; Triglycerides

1972
Current views on cholesterol metabolism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1974, Volume: Suppl 4

    Topics: Adipose Tissue; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Dietary Fats; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Intestinal Mucosa; Liver; Obesity; Sterols

1974
Measures to reduce the serum lipid levels in coronary heart disease.
    The Medical clinics of North America, 1968, Volume: 52, Issue:5

    Topics: Adult; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Fats; Estrogens; Humans; Hypercholesterolemia; Lipids; Middle Aged; Neomycin; Nicotinic Acids; Sterols

1968
Xanthomatosis associated with hyperlipoproteinemia.
    The Journal of investigative dermatology, 1970, Volume: 55, Issue:2

    Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Propionates; Thyroxine; Triglycerides; Xanthomatosis

1970
Hypolipidemic drugs and hyperlipoproteinemia.
    Annals of the New York Academy of Sciences, 1971, Jul-06, Volume: 179

    Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Lipoproteins; Models, Biological; Nicotinic Acids; Thyroxine; Triglycerides

1971
Dietary aspects of atheroslcerosis and thrombosis.
    Internationale Zeitschrift fur Vitaminforschung. International journal of vitamin research. Journal international de vitaminologie, 1968, Volume: 38, Issue:5

    Topics: Animals; Arachis; Arteriosclerosis; Butter; Cholesterol; Cholestyramine Resin; Coronary Disease; Depression, Chemical; Diet; Diet, Atherogenic; Dietary Fats; Fatty Acids, Essential; Glycine max; Haplorhini; Humans; Hypercholesterolemia; Lipids; Medicago sativa; Rabbits; Rats; Thrombosis; Triglycerides; Zea mays

1968

Trials

101 trial(s) available for cholestyramine resin and Hypercholesterolemia

ArticleYear
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1994, Issue:77

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1994
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.
    Stroke, 2010, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Cholestyramine Resin; Endarterectomy, Carotid; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lymphocyte Count; Macrophages; Male; Pyrroles; Sitosterols

2010
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    American heart journal, 2004, Volume: 148, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Cholesterol, LDL; Cholestyramine Resin; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Middle Aged; Prospective Studies; Simvastatin

2004
Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
    Clinical therapeutics, 2004, Volume: 26, Issue:11

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2004
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.
    Atherosclerosis, 1982, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins B; Cholestyramine Resin; Dose-Response Relationship, Drug; Female; Humans; Hypercholesterolemia; Lipoprotein(a); Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged

1982
Pharmacological trials: primary and secondary prevention of coronary heart disease.
    Preventive medicine, 1983, Volume: 12, Issue:1

    Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone

1983
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
    Circulation, 1984, Volume: 69, Issue:2

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides

1984
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
    JAMA, 1984, Jan-20, Volume: 251, Issue:3

    Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Mortality

1984
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
    JAMA, 1984, Jan-20, Volume: 251, Issue:3

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male

1984
Lowered cholesterol decreases heart disease.
    Science (New York, N.Y.), 1984, Jan-27, Volume: 223, Issue:4634

    Topics: Adult; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Double-Blind Method; Heart Diseases; Humans; Hypercholesterolemia; Male; Middle Aged; Risk

1984
Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    The American journal of cardiology, 1984, Aug-27, Volume: 54, Issue:5

    Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Random Allocation

1984
Lipid Research Clinics Program.
    JAMA, 1984, Nov-09, Volume: 252, Issue:18

    Topics: Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged

1984
Hypercholesterolaemia and coronary heart disease: an answer.
    British medical journal (Clinical research ed.), 1984, Feb-11, Volume: 288, Issue:6415

    Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged

1984
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:11

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Apolipoproteins A; Apolipoproteins C; Apolipoproteins E; Bile Acids and Salts; Cholestyramine Resin; Double-Blind Method; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipoproteins; Male; Middle Aged; Triglycerides

1995
Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
    The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2

    Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Cohort Studies; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Safety; Triglycerides

1995
Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
    The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2

    Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Longitudinal Studies; Male; Safety

1995
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2

    Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Male; Middle Aged; Risk Factors; Triglycerides

1995
Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
    The American journal of cardiology, 1995, Jul-13, Volume: 76, Issue:2

    Topics: Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Indoles; Information Systems; Longitudinal Studies; Male; Middle Aged; Placebos; Risk Factors; Triglycerides

1995
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:8

    Topics: Apolipoprotein A-I; Arteriosclerosis; Cholesterol, HDL; Cholestyramine Resin; Female; Femoral Artery; Humans; Hypercholesterolemia; Male; Middle Aged; Probucol; Radiography; Regression Analysis; Sweden

1995
Probucol treatment decreases serum concentrations of diet-derived antioxidants.
    Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:8

    Topics: Antioxidants; Cholestyramine Resin; Diet; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Patient Compliance; Probucol; Regression Analysis; Sweden

1995
Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
    Archives of family medicine, 1994, Volume: 3, Issue:11

    Topics: Abdominal Pain; Adult; Aged; Analysis of Variance; Cholestyramine Resin; Constipation; Diarrhea; Double-Blind Method; Female; Flatulence; Gastrointestinal Diseases; Heartburn; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Psyllium

1994
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
    The New England journal of medicine, 1995, Feb-23, Volume: 332, Issue:8

    Topics: Acetylcholine; Anticholesteremic Agents; Antioxidants; Cholestyramine Resin; Coronary Artery Disease; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Probucol; Regression Analysis; Vasoconstriction; Vasodilation

1995
Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia.
    The American journal of clinical nutrition, 1995, Volume: 61, Issue:2

    Topics: Adult; Aged; Cholesterol, Dietary; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Sitosterols

1995
Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Archives of internal medicine, 1995, Feb-27, Volume: 155, Issue:4

    Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Severity of Illness Index; Treatment Outcome

1995
HBPRCA Astra Award. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:10

    Topics: Acetylcholine; Adult; Australia; Awards and Prizes; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Endothelium, Vascular; Female; Fish Oils; Forearm; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Regional Blood Flow; Simvastatin

1994
Effects of variable doses and formulations of cholestyramine on elevated serum low-density lipoprotein cholesterol.
    The American journal of cardiology, 1995, Apr-01, Volume: 75, Issue:10

    Topics: Adult; Aged; Cholesterol, LDL; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Middle Aged; Powders; Prospective Studies; Tablets

1995
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
    European journal of clinical pharmacology, 1994, Volume: 46, Issue:5

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Diet; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Lipids; Patient Compliance

1994
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
    The American journal of cardiology, 1994, Nov-01, Volume: 74, Issue:9

    Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Female; Femoral Artery; Humans; Hypercholesterolemia; Image Processing, Computer-Assisted; Male; Middle Aged; Probucol; Radiography

1994
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
    Annals of internal medicine, 1994, Sep-15, Volume: 121, Issue:6

    Topics: Adult; Aged; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Risk Factors

1994
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
    Annals of internal medicine, 1994, Apr-01, Volume: 120, Issue:7

    Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Patient Compliance; Single-Blind Method; Triglycerides

1994
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    JAMA, 1994, Apr-06, Volume: 271, Issue:13

    Topics: Adult; Aged; Case-Control Studies; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Risk Factors

1994
Pharmacokinetics of fluvastatin and specific drug interactions.
    American journal of hypertension, 1993, Volume: 6, Issue:11 Pt 2

    Topics: Adolescent; Adult; Aged; Aging; Biological Availability; Cholestyramine Resin; Diet; Digoxin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Propranolol; Sex Characteristics; Time Factors; Triglycerides

1993
Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Archives of internal medicine, 1993, Jun-14, Volume: 153, Issue:11

    Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Creatine Kinase; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Liver; Male; Middle Aged; Placebos; Pravastatin; Safety; Triglycerides

1993
The acceptability of resin therapy to patients attending a hospital lipid clinic.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Surveys and Questionnaires

1995
Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Gut, 1995, Volume: 37, Issue:5

    Topics: Anticholesteremic Agents; Bile; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Gallbladder; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Prospective Studies; Simvastatin; Ultrasonography

1995
Hypercholesterolemia with cholesterol-enriched LDL and normal levels of LDL-apolipoprotein B. Effects of the step I diet and bile acid sequestrants on the cholesterol content of LDL.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:4

    Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Base Sequence; Cholesterol; Cholestyramine Resin; Diet, Fat-Restricted; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Molecular Probes; Molecular Sequence Data; Polymerase Chain Reaction; Reference Values; Single-Blind Method

1996
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1996, Volume: 77A

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1996
[Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Medicina clinica, 1996, May-25, Volume: 106, Issue:20

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Triglycerides

1996
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    The New England journal of medicine, 1997, Jan-16, Volume: 336, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Hypercholesterolemia; Life Tables; Lovastatin; Male; Middle Aged; Saphenous Vein; Treatment Outcome; Warfarin

1997
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial.
    The Journal of pediatrics, 1997, Volume: 130, Issue:2

    Topics: Adolescent; Anticholesteremic Agents; Attitude to Health; Child; Cholestyramine Resin; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Lipids; Male; Patient Acceptance of Health Care; Patient Compliance; Powders; Tablets; Time Factors

1997
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
    The American journal of cardiology, 1997, Sep-15, Volume: 80, Issue:6

    Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Triglycerides

1997
Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
    Atherosclerosis, 1998, Volume: 137, Issue:1

    Topics: Adult; Anticholesteremic Agents; Arthralgia; Atorvastatin; Brachial Artery; Cholestyramine Resin; Drug Therapy, Combination; Endothelium, Vascular; Exanthema; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome; Ultrasonography

1998
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
    Journal of internal medicine, 1998, Volume: 243, Issue:5

    Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Primary Health Care; Sex Factors; Sweden; Treatment Outcome

1998
Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
    Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome; Triglycerides

1998
[Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
    Zeitschrift fur Kardiologie, 1999, Volume: 88, Issue:4

    Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Simvastatin

1999
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
    Zeitschrift fur Kardiologie, 1999, Volume: 88, Issue:8

    Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome

1999
Achievement of target plasma cholesterol levels in hypercholesterolaemic patients being treated in general practice.
    Atherosclerosis, 2000, Volume: 149, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Family Practice; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Linear Models; Logistic Models; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome

2000
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Postgraduate medical journal, 1975, Volume: 51, Issue:8

    Topics: Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids

1975
A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
    British journal of clinical pharmacology, 1977, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Liver Function Tests; Male; Middle Aged; Nicotinic Acids; Triglycerides

1977
The effect of cholestyramine on serum lipids and platelet aggregation of hypercholesterolemic children (type II A) while on high linoleic acid diet.
    Acta paediatrica Scandinavica, 1977, Volume: 66, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hypercholesterolemia; Linoleic Acids; Lipids; Placebos; Platelet Aggregation; Triglycerides

1977
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
    Acta medica Scandinavica, 1977, Volume: 202, Issue:3

    Topics: Calcium; Calcium Carbonate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias

1977
Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
    The Journal of clinical investigation, 1979, Volume: 64, Issue:5

    Topics: Adult; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feces; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Neomycin; Sitosterols

1979
[Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
    La Nouvelle presse medicale, 1976, Mar-13, Volume: 5, Issue:11

    Topics: Acidosis; Bacteria; Bile Acids and Salts; Celiac Disease; Cholestyramine Resin; Clinical Trials as Topic; Constipation; Diarrhea, Infantile; Endotoxins; Female; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Male; Poisoning

1976
Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
    Atherosclerosis, 1976, Volume: 24, Issue:3

    Topics: Acacia; Adult; Anion Exchange Resins; Cholesterol; Cholestyramine Resin; DEAE-Dextran; Dextrans; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Humans; Hypercholesterolemia; Ion Exchange Resins; Male; Middle Aged; Steroids; Sterols; Triglycerides

1976
Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1992, Volume: 12, Issue:7

    Topics: Adult; Cholesterol; Cholestyramine Resin; Dietary Fiber; Female; Galactans; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Mannans; Middle Aged; Plant Gums; Sterols

1992
Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
    The Medical journal of Australia, 1992, Nov-02, Volume: 157, Issue:9

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Safety; Treatment Outcome; Triglycerides

1992
[Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1992, Nov-30, Volume: 112, Issue:29

    Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Triglycerides

1992
Effects of long-term cholestyramine administration on vitamin D and parathormone levels in middle-aged men with hypercholesterolemia.
    The Journal of laboratory and clinical medicine, 1992, Volume: 119, Issue:4

    Topics: Calcium; Cholestyramine Resin; Humans; Hypercholesterolemia; Male; Middle Aged; Parathyroid Hormone; Regression Analysis; Time Factors; Vitamin D

1992
Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
    Annals of medicine, 1992, Volume: 24, Issue:2

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Triglycerides

1992
The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Archives of internal medicine, 1992, Volume: 152, Issue:7

    Topics: Cause of Death; Cholelithiasis; Cholestyramine Resin; Cohort Studies; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Male; Neoplasms; Primary Prevention; Survival Analysis

1992
Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:4

    Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Blood Pressure; Body Weight; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Female; Galactans; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Mannans; Middle Aged; Plant Gums

1991
Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.
    Atherosclerosis, 1991, Volume: 91 Suppl

    Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lens, Crystalline; Lipids; Liver; Lovastatin; Male; Middle Aged; Simvastatin

1991
[Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
    Medizinische Klinik (Munich, Germany : 1983), 1991, Mar-15, Volume: 86, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Female; Gemfibrozil; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides

1991
Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
    Archives of internal medicine, 1991, Volume: 151, Issue:2

    Topics: Adult; Aged; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Gemfibrozil; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Triglycerides

1991
Comparison of the efficacy of Questran Light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levels.
    The American journal of cardiology, 1991, Mar-01, Volume: 67, Issue:6

    Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Energy Intake; Humans; Hypercholesterolemia; Male; Middle Aged; Powders

1991
[Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Recenti progressi in medicina, 1991, Volume: 82, Issue:3

    Topics: Adult; Age Factors; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Simvastatin; Time Factors

1991
HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    The Quarterly journal of medicine, 1990, Volume: 74, Issue:274

    Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Naphthalenes; Phenotype; Pravastatin; Simvastatin; Time Factors

1990
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Phospholipids; Pravastatin; Randomized Controlled Trials as Topic; Triglycerides

1990
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:12

    Topics: Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides

1990
Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia.
    The American journal of cardiology, 1990, Mar-20, Volume: 65, Issue:12

    Topics: Bezafibrate; Cholestyramine Resin; Double-Blind Method; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Probucol; Randomized Controlled Trials as Topic; Simvastatin

1990
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemia.
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:4

    Topics: Bezafibrate; Cholestyramine Resin; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Randomized Controlled Trials as Topic

1990
Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    The Medical journal of Australia, 1990, May-07, Volume: 152, Issue:9

    Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Australia; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides

1990
Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Archives of internal medicine, 1990, Volume: 150, Issue:2

    Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Cataract; Cholesterol; Cholestyramine Resin; Creatine Kinase; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides

1990
Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    European journal of clinical pharmacology, 1989, Volume: 36, Issue:5

    Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Apoproteins; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Patient Compliance; Simvastatin; Time Factors

1989
Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
    Metabolism: clinical and experimental, 1989, Volume: 38, Issue:2

    Topics: Adult; Bezafibrate; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Triglycerides

1989
Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
    Australian and New Zealand journal of medicine, 1989, Volume: 19, Issue:4

    Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Random Allocation; Simvastatin

1989
Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
    Journal of internal medicine, 1989, Volume: 226, Issue:5

    Topics: Adult; Aged; Alanine Transaminase; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Random Allocation; Simvastatin; Time Factors

1989
[Is hypolipemic treatment effective as a preventive measure?].
    Przeglad lekarski, 1989, Volume: 46, Issue:7

    Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipoproteinemias; International Cooperation; Male; Middle Aged

1989
Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
    Acta cardiologica, 1989, Volume: 44, Issue:5

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin

1989
Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
    Lancet (London, England), 1987, Jul-11, Volume: 2, Issue:8550

    Topics: Adult; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Probability; Regression Analysis

1987
A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA, 1988, Jul-15, Volume: 260, Issue:3

    Topics: Adult; Aged; Alkaline Phosphatase; Apolipoproteins; Cholesterol; Cholestyramine Resin; Creatine Kinase; Female; Humans; Hypercholesterolemia; Lipoproteins; Lovastatin; Male; Middle Aged; Random Allocation; Transaminases; Triglycerides

1988
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    The American journal of cardiology, 1988, Jul-25, Volume: 62, Issue:3

    Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Female; Femoral Artery; Humans; Hypercholesterolemia; Lipids; Male; Phenols; Placebos; Probucol; Random Allocation; Remission Induction; Research Design; Sweden

1988
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
    Circulation, 1987, Volume: 76, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk

1987
Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
    Arzneimittel-Forschung, 1987, Volume: 37, Issue:6

    Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Lipoproteins, VLDL; Male; Middle Aged; Random Allocation; Triglycerides

1987
Seasonal cholesterol cycles: the Lipid Research Clinics Coronary Primary Prevention Trial placebo group.
    Circulation, 1987, Volume: 76, Issue:6

    Topics: Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Climate; Clinical Trials as Topic; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Primary Prevention; Random Allocation; Research Design; Seasons; Triglycerides; United States

1987
Differentiated dosage of microporous colestyramine and its double-blind comparison with a placebo in hypercholesterolaemic patients.
    International journal of clinical pharmacology research, 1987, Volume: 7, Issue:6

    Topics: Adult; Cholesterol; Cholestyramine Resin; Dosage Forms; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged

1987
Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
    The American journal of clinical nutrition, 1986, Volume: 44, Issue:4

    Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Weight; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Smoking

1986
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
    Circulation, 1986, Volume: 74, Issue:6

    Topics: Adult; Cholesterol, HDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Prognosis; Random Allocation; Risk

1986
The Lipid Research Clinics Coronary Primary Prevention Trial.
    Drugs, 1986, Volume: 31 Suppl 1

    Topics: Adult; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Death, Sudden; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction

1986
Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    International journal of clinical pharmacology, therapy, and toxicology, 1986, Volume: 24, Issue:9

    Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Phenols; Probucol; Random Allocation; Triglycerides

1986
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
    JAMA, 1985, Apr-12, Volume: 253, Issue:14

    Topics: Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Random Allocation; Research Design; Statistics as Topic

1985
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Monographs on atherosclerosis, 1985, Volume: 13

    Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Digestive System; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Risk

1985
Effect of plant sterols on serum lipids and atherosclerosis.
    Pharmacology & therapeutics, 1985, Volume: 31, Issue:3

    Topics: Absorption; Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Food; Humans; Hypercholesterolemia; Phytosterols; Risk; Sitosterols

1985
Treatment of essential hyperlipidaemia.
    Lancet (London, England), 1969, Dec-20, Volume: 2, Issue:7634

    Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Xanthomatosis

1969
The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    The Journal of clinical pharmacology and new drugs, 1972, Volume: 12, Issue:7

    Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Depression, Chemical; Ethers, Cyclic; Female; Humans; Hypercholesterolemia; Ion Exchange Resins; Male; Middle Aged; Placebos; Polyamines; Time Factors; Triglycerides

1972
[Treatment of hypercholesteremia with cholestyramine].
    Therapeutique (La Semaine des hopitaux), 1972, Volume: 48, Issue:3

    Topics: Adult; Aged; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos

1972
Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Annals of internal medicine, 1973, Volume: 79, Issue:1

    Topics: Adult; Age Factors; Body Weight; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Placebos; Sex Factors; Triglycerides; Xanthomatosis

1973
[Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Lakartidningen, 1974, Sep-04, Volume: 71, Issue:36

    Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Diet; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Triglycerides

1974
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
    Acta medica Scandinavica, 1973, Volume: 194, Issue:3

    Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clofibrate; Constipation; Depression, Chemical; Diarrhea; Drug Therapy, Combination; Dyspepsia; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nausea; Neomycin

1973
Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.
    California medicine, 1967, Volume: 106, Issue:4

    Topics: Adult; Aged; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Male; Middle Aged

1967
Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
    British medical journal, 1971, Jul-03, Volume: 3, Issue:5765

    Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Constipation; Dextrans; Drug Synergism; Humans; Hypercholesterolemia; Propionates

1971

Other Studies

211 other study(ies) available for cholestyramine resin and Hypercholesterolemia

ArticleYear
Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial.
    Clinical trials (London, England), 2020, Volume: 17, Issue:5

    Topics: Adult; Anticholesteremic Agents; Bias; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Intention to Treat Analysis; Lipids; Logistic Models; Male; Medication Adherence; Middle Aged; Primary Prevention; Randomized Controlled Trials as Topic

2020
Cocoa powder extracts exhibits hypolipidemic potential in cholesterol-fed rats.
    African journal of medicine and medical sciences, 2012, Volume: 41 Suppl

    Topics: Animals; Anticholesteremic Agents; Antioxidants; Biological Availability; Cacao; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Hypercholesterolemia; Lipid Metabolism; Male; Plant Extracts; Powders; Rats; Rats, Wistar; Treatment Outcome

2012
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients.
    Steroids, 2008, Volume: 73, Issue:11

    Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Complement C4; Data Interpretation, Statistical; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Kinetics; Male; Middle Aged; Reference Standards; Simvastatin

2008
Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet.
    Vascular health and risk management, 2008, Volume: 4, Issue:1

    Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diet; Hypercholesterolemia; Lipid Peroxidation; Lipids; Male; Phytotherapy; Plant Leaves; Rats; Rats, Wistar; Vernonia

2008
Steam cooking significantly improves in vitro bile acid binding of collard greens, kale, mustard greens, broccoli, green bell pepper, and cabbage.
    Nutrition research (New York, N.Y.), 2008, Volume: 28, Issue:6

    Topics: Anticholesteremic Agents; Bile Acids and Salts; Brassica; Capsicum; Cellulose; Cholestyramine Resin; Cooking; Dietary Fiber; Humans; Hypercholesterolemia; Phytotherapy; Spinacia oleracea; Vegetables

2008
Nitroxide derivatives for imaging of hypercholesterolemia-induced kidney dysfunction and assessing the effectiveness of antilipidemic drugs.
    Molecular pharmaceutics, 2011, Oct-03, Volume: 8, Issue:5

    Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Contrast Media; Cyclic N-Oxides; Drug Monitoring; Ezetimibe; Gadolinium DTPA; Humans; Hypercholesterolemia; Kidney; Kinetics; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Pyrrolidines; Renal Insufficiency

2011
LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2002, Volume: 12, Issue:1

    Topics: Aged; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Simvastatin; Sitosterols; Treatment Outcome

2002
Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins?
    Heart (British Cardiac Society), 2002, Volume: 88, Issue:4

    Topics: Anticholesteremic Agents; Atorvastatin; Baroreflex; Blood Pressure; Cholestyramine Resin; Heart Rate; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Norepinephrine; Pyrroles; Sympathomimetics

2002
Lack of cholesterol-lowering effect of graded doses of cholestyramine in children with Alagille syndrome: a pilot study.
    Journal of pediatric gastroenterology and nutrition, 2003, Volume: 36, Issue:1

    Topics: Alagille Syndrome; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Female; Humans; Hypercholesterolemia; Male; Pilot Projects; Triglycerides

2003
The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine.
    The New England journal of medicine, 1961, Sep-07, Volume: 265

    Topics: Bile Duct Diseases; Bile Ducts; Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver Cirrhosis, Biliary; Pruritus

1961
Hormonal hypercholesterolemia in the dog: influence of niacin, niacinamide, benzmalecene, and cholestyramine resin.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1963, Volume: 112

    Topics: Animals; Cholestyramine Resin; Dogs; Hypercholesterolemia; Ion Exchange Resins; Maleates; Niacin; Niacinamide; Nicotinic Acids

1963
Treatment of pruritus of obstructive jaundice with cholestyramine.
    British medical journal, 1963, Jan-26, Volume: 1, Issue:5325

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Ion Exchange Resins; Jaundice; Jaundice, Obstructive; Pruritus

1963
METABOLIC CHANGES INDUCED IN ELDERLY PATIENTS WITH A CHOLESTEROL LOWERING RESIN, CHOLESTYRAMINE.
    Metabolism: clinical and experimental, 1964, Volume: 13

    Topics: Aged; Anticholesteremic Agents; Blood Urea Nitrogen; Carbon Dioxide; Cholesterol; Cholestyramine Resin; Drug Therapy; Geriatrics; Humans; Hypercholesterolemia; Ion Exchange Resins; Lipoproteins; Metabolism; Toxicology; Urea; Urine

1964
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
    JAMA, 1965, Apr-26, Volume: 192

    Topics: Biomedical Research; Blood Chemical Analysis; Cholesterol; Cholestyramine Resin; Drug Therapy; Humans; Hypercholesterolemia; Ion Exchange Resins; Metabolism; Xanthomatosis

1965
THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS.
    Gastroenterology, 1965, Volume: 48

    Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood; Calcium; Cholesterol; Cholestyramine Resin; Drug Therapy; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver Cirrhosis; Liver Cirrhosis, Biliary; Phosphorus; Prothrombin Time; Pruritus; Serum Albumin; Serum Globulins; Toxicology

1965
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
    The American journal of cardiology, 2004, Sep-15, Volume: 94, Issue:6

    Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome

2004
Lipid-lowering drugs.
    Nursing older people, 2004, Volume: 16, Issue:9

    Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Ezetimibe; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Risk Factors; Treatment Outcome

2004
Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2006, Volume: 6, Issue:3

    Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Meta-Analysis as Topic; Pravastatin; Pyrroles; Risk Factors; Simvastatin; Spain

2006
Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats.
    Life sciences, 2007, Jan-16, Volume: 80, Issue:6

    Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Disease Models, Animal; Gene Expression; Hypercholesterolemia; Lipids; Liver; Male; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction

2007
Hypolipidemic effect of Telfairia occidentalis (fluted pumpkin) in rats fed a cholesterol-rich diet.
    Journal of medicinal food, 2007, Volume: 10, Issue:2

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholestyramine Resin; Cucurbitaceae; Diet; Hypercholesterolemia; Hypolipidemic Agents; Male; Mitochondria, Liver; Phytotherapy; Plant Leaves; Rats; Rats, Wistar; Triglycerides

2007
Bounds on direct effects in the presence of confounded intermediate variables.
    Biometrics, 2008, Volume: 64, Issue:3

    Topics: Anticholesteremic Agents; Biometry; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Programming, Linear; Randomized Controlled Trials as Topic; Treatment Outcome

2008
The biologic consequences of hypercholesteremia in man and its treatment.
    Angiology, 1967, Volume: 18, Issue:2

    Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Diet Therapy; Female; Humans; Hypercholesterolemia; Male; Middle Aged

1967
Treatment of hypercholesteremia with cholestyramine, a bile acid sequestering resin.
    Vascular diseases, 1967, Volume: 4, Issue:5

    Topics: Adult; Aged; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged

1967
[Hepatitis caused by procetofen].
    La Nouvelle presse medicale, 1980, Oct-11, Volume: 9, Issue:37

    Topics: Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Female; Fenofibrate; gamma-Glutamylcyclotransferase; Humans; Hypercholesterolemia; Middle Aged; Phosphoric Monoester Hydrolases; Propionates

1980
Probucol with cholestyramine.
    Lancet (London, England), 1981, Jul-11, Volume: 2, Issue:8237

    Topics: Cholestyramine Resin; Drug Synergism; Humans; Hypercholesterolemia; Phenols; Probucol

1981
Partial ileal bypass for hypercholesterolaemia.
    Lancet (London, England), 1982, Jan-09, Volume: 1, Issue:8263

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Ileum

1982
The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol.
    The American journal of cardiology, 1984, Aug-27, Volume: 54, Issue:5

    Topics: Adrenergic beta-Antagonists; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Triglycerides

1984
Effects of cholestyramine on low density lipoprotein binding sites on liver membranes from rabbits with endogenous hypercholesterolemia induced by a wheat starch-casein diet.
    The Journal of biological chemistry, 1982, Apr-10, Volume: 257, Issue:7

    Topics: Animals; Caseins; Cell Membrane; Cholestyramine Resin; Dietary Carbohydrates; Dietary Proteins; Hypercholesterolemia; Kinetics; Lipoproteins, LDL; Liver; Male; Rabbits; Receptors, Cell Surface; Receptors, LDL

1982
Catabolism of low density lipoproteins by perfused rabbit livers: cholestyramine promotes receptor-dependent hepatic catabolism of low density lipoproteins.
    Proceedings of the National Academy of Sciences of the United States of America, 1982, Volume: 79, Issue:13

    Topics: Animals; Cell Membrane; Cholesterol, Dietary; Cholestyramine Resin; Edetic Acid; Hypercholesterolemia; Kinetics; Lipoproteins, LDL; Liver; Male; Rabbits; Receptors, Cell Surface; Receptors, LDL

1982
Management of hypercholesterolaemia and cholestyramine.
    The New Zealand medical journal, 1984, Apr-25, Volume: 97, Issue:754

    Topics: Age Factors; Aged; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Middle Aged

1984
Time to treat cholesterol seriously.
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:3

    Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Middle Aged

1984
Relationship between metabolism and composition of low density lipoproteins in rabbits on semi-purified diet.
    Artery, 1983, Volume: 11, Issue:4

    Topics: Animals; Apoproteins; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Lipoproteins, LDL; Male; Rabbits

1983
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
    Preventive medicine, 1983, Volume: 12, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides

1983
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Preventive medicine, 1983, Volume: 12, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines

1983
LRC-CPP trial.
    The Medical journal of Australia, 1984, Jun-09, Volume: 140, Issue:12

    Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia

1984
[Definition and treatment of hypercholesterolemia; consequences of the Lipid Research Clinics study].
    Nederlands tijdschrift voor geneeskunde, 1984, Jun-09, Volume: 128, Issue:23

    Topics: Adult; Cholestyramine Resin; Coronary Disease; Diet; Health Education; Humans; Hypercholesterolemia; Male; Middle Aged

1984
Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis.
    European journal of clinical investigation, 1980, Volume: 10, Issue:1

    Topics: Absorption; Adult; Arteriosclerosis; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary Disease; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Male; Phytosterols; Squalene; Xanthomatosis

1980
[Drug therapy of hypercholesterinemias (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1980, Mar-28, Volume: 122, Issue:13

    Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols

1980
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
    JPMA. The Journal of the Pakistan Medical Association, 1981, Volume: 31, Issue:11

    Topics: Adult; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Male; Polyamines

1981
The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Atherosclerosis, 1980, Volume: 35, Issue:4

    Topics: Animals; Anticholesteremic Agents; Chickens; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, VLDL; Lovastatin; Male; Naphthalenes; Rats

1980
Synergistic effects of probucol and cholestyramine to lower serum cholesterol.
    Journal of clinical pharmacology, 1981, Volume: 21, Issue:1

    Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Dietary Fats; Drug Synergism; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Phenols; Probucol

1981
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:3

    Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Pravastatin; Triglycerides

1993
Serum retinol levels throughout 2 years of cholesterol-lowering therapy.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:3

    Topics: Adult; Cholestyramine Resin; Diet; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Retinol-Binding Proteins; Vitamin A

1995
The effect of poor compliance and treatment side effects on sample size requirements in randomized clinical trials.
    Journal of biopharmaceutical statistics, 1994, Volume: 4, Issue:2

    Topics: Cholestyramine Resin; Drug-Related Side Effects and Adverse Reactions; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic; Sampling Studies; Treatment Refusal

1994
Malabsorption of thyroid hormone with cholestyramine administration.
    Connecticut medicine, 1994, Volume: 58, Issue:2

    Topics: Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Goiter, Nodular; Humans; Hypercholesterolemia; Middle Aged; Thyrotropin; Thyroxine

1994
Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
    Lancet (London, England), 1993, Jun-12, Volume: 341, Issue:8859

    Topics: Acetylcholine; Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Vessels; Endothelium, Vascular; Humans; Hypercholesterolemia; Male; Middle Aged; Nitroglycerin; Vasodilation

1993
[Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
    Vnitrni lekarstvi, 1994, Volume: 40, Issue:2

    Topics: Adult; Apolipoproteins B; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Triglycerides

1994
New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.
    American pharmacy, 1993, Volume: NS33, Issue:7

    Topics: Algorithms; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxidoreductases; Risk Factors

1993
Choice of cholesterol-lowering drugs.
    The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol

1993
Serum concentration of 7 alpha-hydroxycholesterol as an indicator of bile acid synthesis in humans.
    Journal of lipid research, 1995, Volume: 36, Issue:9

    Topics: Bile Acids and Salts; Cholestyramine Resin; Feces; Freezing; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver Cirrhosis; Male; Oxidation-Reduction; Reference Values; Reproducibility of Results; Sterols

1995
Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:1

    Topics: Animals; Anticholesteremic Agents; Bile Acids and Salts; Cathartics; Cholesterol, LDL; Cholestyramine Resin; Cricetinae; Drug Combinations; Hypercholesterolemia; Male; Mesocricetus; Psyllium

1996
[Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
    Fortschritte der Medizin, 1996, May-20, Volume: 114, Issue:14

    Topics: Anion Exchange Resins; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia

1996
[Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 1995, Volume: 31, Issue:6

    Topics: Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypercholesterolemia; Male; Mice; Mice, Inbred ICR; Pravastatin; Vascular Diseases; Vasodilation

1995
Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis.
    Journal of lipid research, 1996, Volume: 37, Issue:10

    Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Reproducibility of Results; Simvastatin; Xanthomatosis, Cerebrotendinous

1996
[New markers of atherogenic risk: hemorrheological profile in children and adolescents with familial hypercholesterolemia].
    Anales espanoles de pediatria, 1996, Volume: 45, Issue:4

    Topics: Adolescent; Anticholesteremic Agents; Blood Viscosity; Child, Preschool; Cholestyramine Resin; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hypercholesterolemia; Male

1996
Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
    Journal of atherosclerosis and thrombosis, 1995, Volume: 2, Issue:1

    Topics: Acyl Coenzyme A; Adult; Anticholesteremic Agents; Cholestyramine Resin; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Phytosterols; Pravastatin

1995
Lipid-lowering drugs and mortality.
    The British journal of psychiatry : the journal of mental science, 1997, Volume: 170

    Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Pravastatin; Treatment Outcome

1997
Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:1

    Topics: Anticholesteremic Agents; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholestyramine Resin; Female; Glycoproteins; Humans; Hypercholesterolemia; Lipids; Male

1997
Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
    Chest, 1997, Volume: 112, Issue:4

    Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Echocardiography; Female; Follow-Up Studies; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Lung Transplantation; Male; Middle Aged; Myocardial Ischemia; Probucol; Radionuclide Angiography; Retrospective Studies; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left

1997
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.
    European journal of medical research, 1995, Oct-16, Volume: 1, Issue:1

    Topics: Adult; Apolipoproteins B; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Pyrazines

1995
Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS).
    Atherosclerosis, 1998, Volume: 140, Issue:2

    Topics: Allylamine; Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Aryl Hydrocarbon Hydroxylases; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Cricetinae; Cytochrome P-450 Enzyme System; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Lipoproteins; Liver; Male; Mesocricetus; Polyamines; Steroid Hydroxylases

1998
[Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
    Revue medicale de Liege, 1998, Volume: 53, Issue:11

    Topics: Acarbose; Anion Exchange Resins; Anti-Obesity Agents; Cholestyramine Resin; Diabetes Mellitus; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Intestine, Small; Lactones; Lipase; Metabolic Diseases; Orlistat; Trisaccharides

1998
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992.
    Transfusion science, 1993, Volume: 14, Issue:3

    Topics: Adult; Aged; Blood Component Removal; Child; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dextran Sulfate; Humans; Hypercholesterolemia; Immunosorbent Techniques; Lovastatin; Middle Aged; Niacin; Pilot Projects

1993
Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden.
    PharmacoEconomics, 1992, Volume: 1, Issue:3

    Topics: Adult; Cholestyramine Resin; Coronary Disease; Cost Savings; Cost-Benefit Analysis; Health Care Costs; Humans; Hypercholesterolemia; Life Expectancy; Lovastatin; Male; Middle Aged; Multivariate Analysis; Sweden

1992
Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses.
    Circulation research, 2000, Nov-10, Volume: 87, Issue:10

    Topics: Animals; Antioxidants; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Diet, Atherogenic; Fatty Acids; Female; Fetus; Hypercholesterolemia; Lipid Peroxidation; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rabbits; Remission Induction; Triglycerides; Vitamin E

2000
Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.
    International journal of hematology, 2001, Volume: 73, Issue:3

    Topics: Adult; Anemia, Hemolytic; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Chelating Agents; Chenodeoxycholic Acid; Cholesterol; Cholestyramine Resin; Drug Eruptions; Drug Therapy, Combination; Erythrocyte Membrane; Flunarizine; Humans; Hyperbilirubinemia; Hypercholesterolemia; Liver Cirrhosis, Alcoholic; Male; Membrane Lipids; Pentoxifylline; Phospholipids

2001
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire international, 1999, Volume: 8, Issue:42

    Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Pravastatin; Treatment Outcome

1999
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.
    Circulation research, 2001, Nov-23, Volume: 89, Issue:11

    Topics: Animals; Anticholesteremic Agents; Antioxidants; Aorta; Aortic Diseases; Arteriosclerosis; Cholestyramine Resin; Disease Progression; Female; Hypercholesterolemia; Linoleic Acid; Lipid Peroxidation; Malondialdehyde; Pregnancy; Rabbits; Vitamin E

2001
Portacaval shunt in four patients with homozygous hypercholesterolaemia.
    Lancet (London, England), 1975, Apr-12, Volume: 1, Issue:7911

    Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fats; Female; Glucose; Homozygote; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Male; Middle Aged; Nicotinic Acids; Parenteral Nutrition; Pedigree; Portacaval Shunt, Surgical; Preoperative Care; Protein Hydrolysates; Triglycerides

1975
Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia.
    Lancet (London, England), 1977, Jan-08, Volume: 1, Issue:8002

    Topics: Administration, Oral; Adolescent; Adult; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Folic Acid; Follow-Up Studies; Humans; Hypercholesterolemia; Lipoproteins, LDL; Triglycerides

1977
Cholestyramine in hypercholesterolaemia.
    Lancet (London, England), 1977, Feb-26, Volume: 1, Issue:8009

    Topics: Child; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia

1977
3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human hair roots.
    Journal of lipid research, 1975, Volume: 16, Issue:1

    Topics: Abetalipoproteinemia; Adolescent; Adult; Alcohol Oxidoreductases; Animals; Carbon Radioisotopes; Child; Cholestyramine Resin; Circadian Rhythm; Coenzymes; Female; Fibroblasts; Genotype; Hair; Humans; Hypercholesterolemia; Lipoproteins, LDL; Liver; Male; Mevalonic Acid; Middle Aged; Rats; Tritium

1975
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    JAMA, 1975, Jul-21, Volume: 233, Issue:3

    Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Nicotinic Acids; Resins, Plant; Triglycerides

1975
Cholestyramine: an effective, twice-daily dosage regimen.
    Annals of internal medicine, 1976, Volume: 85, Issue:3

    Topics: Adult; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypercholesterolemia; Lipoproteins, LDL; Middle Aged

1976
Changes in plasma lipoproteins in subjects treated with the bile acid-sequestering resin polidexide (Secholex).
    Australian and New Zealand journal of medicine, 1976, Volume: 6, Issue:2

    Topics: Adult; Anion Exchange Resins; Apoproteins; Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Male; Triglycerides

1976
A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
    Advances in experimental medicine and biology, 1977, Volume: 82

    Topics: Adolescent; Body Weight; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Lipoproteins, LDL

1977
Acute effects of cholestyramine on serum lipoprotein concentrations in type II hyperlipoproteinaemia.
    Atherosclerosis, 1978, Volume: 29, Issue:1

    Topics: Aged; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides

1978
Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia.
    European journal of clinical investigation, 1977, Volume: 7, Issue:6

    Topics: Adult; Bile Acids and Salts; Child; Cholesterol; Cholestyramine Resin; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ileum; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Steroids

1977
Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias.
    Postgraduate medical journal, 1978, Volume: 54, Issue:629

    Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Coronary Disease; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Risk; Triglycerides

1978
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Postgraduate medical journal, 1975, Volume: 51, Issue:8

    Topics: Cholestyramine Resin; Clofibrate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Niceritrol; Nicotinic Acids; Triglycerides

1975
The baboon as an experimental model in drug testing.
    Advances in experimental medicine and biology, 1977, Volume: 82

    Topics: Animals; Antigen-Antibody Reactions; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Disease Models, Animal; Haplorhini; Hypercholesterolemia; Papio; Serum Albumin, Bovine

1977
Drug management of hypercholesterolemia.
    American heart journal, 1979, Volume: 97, Issue:3

    Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols

1979
Management of hyperlipidemia in diabetes.
    American family physician, 1979, Volume: 19, Issue:4

    Topics: Cholestyramine Resin; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hypercholesterolemia; Hyperlipidemias; Syndrome; Triglycerides

1979
Hypercholesterolaemic arthropathy in primary biliary cirrhosis.
    Annals of the rheumatic diseases, 1979, Volume: 38, Issue:2

    Topics: Arthritis; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Middle Aged

1979
Use of diet and probucol.
    Archives of internal medicine, 1979, Volume: 139, Issue:9

    Topics: Child; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Phenols; Probucol

1979
A practical guide to hyperlipidaemic disorders.
    Modern medicine of Asia, 1977, Volume: 13, Issue:10

    Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids

1977
[Action of cholestyramine on blood lipids].
    Arquivos brasileiros de cardiologia, 1977, Volume: 30, Issue:4

    Topics: Adult; Cholestyramine Resin; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged

1977
A cause of hypercholesterolemia in alloxan diabetic rat.
    Journal of nutritional science and vitaminology, 1978, Volume: 24, Issue:2

    Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Diabetes Mellitus, Experimental; Hypercholesterolemia; Intestine, Small; Liver; Male; Rats; Sterols

1978
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Monatsschrift fur Kinderheilkunde, 1978, Volume: 126, Issue:7

    Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Phospholipids; Polyamines

1978
New microporous cholestyramine analog for treatment of hypercholesterolemia.
    Journal of pharmaceutical sciences, 1978, Volume: 67, Issue:12

    Topics: Adult; Aged; Cholestyramine Resin; Cholic Acids; Colestipol; Constipation; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Suspensions

1978
[Questran].
    Medecine & chirurgie digestives, 1978, Volume: 7, Issue:8

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia

1978
[Resins in the treatment of hypercholesterolemia].
    Medecine & chirurgie digestives, 1978, Volume: 7, Issue:8

    Topics: Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Triglycerides

1978
Treatment of induced cholesteremia and atherosclerosis in rabbits with cholestyramine, niacin and taurine.
    Current therapeutic research, clinical and experimental, 1975, Volume: 18, Issue:4

    Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Male; Nicotinic Acids; Rabbits; Taurine; Time Factors

1975
Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Pediatrics, 1977, Volume: 59, Issue:3

    Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Resins, Plant; Triglycerides

1977
The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia.
    Atherosclerosis, 1977, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Bile Acids and Salts; Child; Cholestyramine Resin; Feces; Female; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Male; Middle Aged; Steroids

1977
Effects of cholestyramine on cholesterol balance parameters and hepatic HMG-CoA reductase and cholesterol-7-alpha-hydroxylase activities in swine.
    Experimental and molecular pathology, 1977, Volume: 26, Issue:3

    Topics: Alcohol Oxidoreductases; Animals; Bile Acids and Salts; Body Weight; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cholestyramine Resin; Diet; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Liver; Male; Microsomes, Liver; Steroid Hydroxylases; Steroids; Swine

1977
[Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
    Semaine des hopitaux. Therapeutique, 1977, Volume: 53, Issue:4

    Topics: Anticholesteremic Agents; Blood Platelet Disorders; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Nicotinic Acids; Tinnitus

1977
Treatment of hyperlipidemias in childhood.
    Advances in experimental medicine and biology, 1977, Volume: 82

    Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Triglycerides

1977
Dextrothyroxine for lowering cholesterol.
    The Medical letter on drugs and therapeutics, 1976, Jun-18, Volume: 18, Issue:13

    Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids

1976
[Treatment of hyperlipidemia].
    Duodecim; laaketieteellinen aikakauskirja, 1976, Volume: 92, Issue:10

    Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids

1976
[Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)].
    Deutsche medizinische Wochenschrift (1946), 1976, Sep-03, Volume: 101, Issue:36

    Topics: Azathioprine; Calcium; Cholangitis; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Osteoporosis; Phenobarbital; Pruritus; Vitamin D

1976
Immunodeficiency, xanthomas and obstructive liver disease.
    The American journal of medicine, 1976, Volume: 61, Issue:3

    Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Child; Cholestyramine Resin; Cholic Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Immunologic Deficiency Syndromes; Liver Diseases; Male; Phenobarbital; Pruritus; Xanthomatosis

1976
Treatment of children with familial hypercholesterolaemia.
    Postgraduate medical journal, 1975, Volume: 51, Issue:8

    Topics: Adolescent; Celiac Disease; Child; Child, Preschool; Cholestyramine Resin; Clofibrate; Fatty Acids, Unsaturated; Female; Folic Acid Deficiency; Follow-Up Studies; Heterozygote; Humans; Hypercholesterolemia; Infant; Male; Phosphorus; Vitamin A; Vitamin E

1975
Letter: Possible ineffective use of cholestyramine.
    The Medical journal of Australia, 1975, Jan-04, Volume: 1, Issue:1

    Topics: Cholestyramine Resin; Hypercholesterolemia

1975
Cholesterol kinetic analysis in normal and cholesterol-fed rabbits; effects of saturated versus polyunsaturated fat and of cholestyramine.
    The Journal of nutrition, 1975, Volume: 105, Issue:6

    Topics: Animals; Body Composition; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Cocos; Diet, Atherogenic; Dietary Fats; Fats, Unsaturated; Hypercholesterolemia; Hyperlipidemias; Kinetics; Male; Oils; Rabbits; Structure-Activity Relationship; Zea mays

1975
The investigation and treatment of hyperlipidaemia in general practice.
    The Practitioner, 1975, Volume: 214, Issue:1281

    Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Practice; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged

1975
Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine.
    Experimental and molecular pathology, 1975, Volume: 23, Issue:1

    Topics: Animals; Bile; Body Composition; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Diet; Feces; Hypercholesterolemia; Male; Swine; Time Factors

1975
The effect of cholestyramine on intestinal absorption.
    Gut, 1975, Volume: 16, Issue:2

    Topics: Animals; Blood Proteins; Calcium; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Erythrocytes; Feces; Folic Acid; Folic Acid Deficiency; Growth; Humans; Hypercholesterolemia; Infant; Intestinal Absorption; Iron; Phosphorus; Prothrombin Time; Rats; Vitamin A; Vitamin B 12; Vitamin E

1975
[Mechanism of action of drugs affecting lipid metabolism].
    Minerva medica, 1975, Oct-06, Volume: 66, Issue:66

    Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipid Mobilization; Nicotinic Acids

1975
Treatment of hypercholesterolaemia in children.
    Lancet (London, England), 1992, Aug-29, Volume: 340, Issue:8818

    Topics: Child; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lovastatin; Male

1992
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    European journal of clinical pharmacology, 1992, Volume: 42, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Pravastatin; Time Factors; Triglycerides

1992
Statistical validation of intermediate endpoints for chronic diseases.
    Statistics in medicine, 1992, Jan-30, Volume: 11, Issue:2

    Topics: Biomarkers; Cholestyramine Resin; Chronic Disease; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Male; Middle Aged; Models, Statistical; Probability; Prospective Studies; Risk Factors

1992
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
    Atherosclerosis, 1992, Volume: 93, Issue:1-2

    Topics: Adult; Animals; Bezafibrate; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Esterification; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Mice; Middle Aged; Pravastatin; Vitamin E

1992
Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues.
    Archives of internal medicine, 1992, Volume: 152, Issue:7

    Topics: Adult; Cholestyramine Resin; Coronary Disease; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Primary Prevention; Survival Rate

1992
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects.
    European journal of clinical investigation, 1992, Volume: 22, Issue:6

    Topics: Adult; Centrifugation, Density Gradient; Cholestyramine Resin; Drug Therapy, Combination; Electrophoresis; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Reference Values

1992
[Cholesterol level 200: prevention and therapy. Specialty Press Conference. Frankfurt, 8 November 1990].
    Der Internist, 1991, Volume: 32, Issue:4 Suppl

    Topics: Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia

1991
Urethral calculi caused by cholestyramine.
    British journal of urology, 1991, Volume: 68, Issue:6

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Male; Middle Aged; Urethra; Urinary Calculi

1991
[The cholesterol question. Disinformed information].
    Giornale italiano di cardiologia, 1991, Volume: 21, Issue:9

    Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Pilot Projects; Risk Factors

1991
Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
    Atherosclerosis, 1991, Volume: 91, Issue:1-2

    Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Heterozygote; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Phenotype; Simvastatin; Triglycerides

1991
[Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Nederlands tijdschrift voor geneeskunde, 1991, Apr-13, Volume: 135, Issue:15

    Topics: Adult; Age Factors; Anticholesteremic Agents; Cholestyramine Resin; Cost-Benefit Analysis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Netherlands; Sex Factors; Simvastatin

1991
Acceptability of cholestyramine and colestipol formulations in three common vehicles.
    Clinical pharmacy, 1991, Volume: 10, Issue:2

    Topics: Adult; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hypercholesterolemia; Male; Prospective Studies; Random Allocation; Taste

1991
Low density lipoprotein receptor levels and the response to dietary and pharmacological intervention in polygenic hypercholesterolemia.
    Clinica chimica acta; international journal of clinical chemistry, 1991, Feb-28, Volume: 197, Issue:1

    Topics: Adult; Apolipoproteins B; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Humans; Hypercholesterolemia; Lymphocytes; Middle Aged; Receptors, LDL

1991
Treatment guidelines for hypercholesterolemia.
    The Journal of practical nursing, 1991, Volume: 41, Issue:1

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Nursing, Practical; Patient Compliance; Patient Education as Topic

1991
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Metabolism: clinical and experimental, 1990, Volume: 39, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Bile Acids and Salts; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Evaluation; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Random Allocation; Triglycerides

1990
[Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Revista medica de Chile, 1990, Volume: 118, Issue:9

    Topics: Adolescent; Adult; Apolipoproteins; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Tolerance; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Time Factors; Triglycerides

1990
Response to diet and cholestyramine in a patient with sitosterolemia.
    Pediatrics, 1990, Volume: 86, Issue:6

    Topics: Arteriosclerosis; Child; Cholestyramine Resin; Combined Modality Therapy; Humans; Hypercholesterolemia; Lipid Metabolism, Inborn Errors; Male; Sitosterols; Xanthomatosis

1990
[Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
    Kardiologiia, 1990, Volume: 30, Issue:8

    Topics: Animals; Cholesterol; Cholestyramine Resin; Guinea Pigs; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Metabolism; Lipids; Lipoproteins, VLDL; Liver; Rats; Triglycerides

1990
Therapy for hypercholesterolemia; standardization of cholesterol measurements.
    JAMA, 1990, Jan-19, Volume: 263, Issue:3

    Topics: Cholesterol; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Hypercholesterolemia; Reference Standards; Thyroid Function Tests

1990
Therapeutic priorities of Canadian internists.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1990, Feb-15, Volume: 142, Issue:4

    Topics: Attitude of Health Personnel; Canada; Cardiovascular Diseases; Cholestyramine Resin; Humans; Hypercholesterolemia; Internal Medicine; Isoniazid; Tuberculosis

1990
Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
    The American journal of clinical nutrition, 1990, Volume: 51, Issue:4

    Topics: Animals; Cholesterol; Cholestyramine Resin; Diet; Disease Models, Animal; Glomerular Filtration Rate; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides

1990
[Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
    Giornale di clinica medica, 1990, Volume: 71, Issue:2

    Topics: Adolescent; Adult; Aged; Cholesterol, HDL; Cholestyramine Resin; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Time Factors

1990
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Atherosclerosis, 1990, Volume: 82, Issue:1-2

    Topics: Aged; Cells, Cultured; Cholesterol; Cholestyramine Resin; Fatty Acids; Female; Food, Formulated; Humans; Hypercholesterolemia; Lipoproteins, LDL; Macrophages; Male; Middle Aged; Oxidation-Reduction; Phenols; Probucol; Receptors, LDL

1990
Effect of cholestyramine in early weaning on later response to serum and fecal steroid levels and cholesterol 7 alpha-hydroxylase activity to high-cholesterol diet in ExHC rats.
    Journal of nutritional science and vitaminology, 1990, Volume: 36, Issue:2

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cholestyramine Resin; Cholic Acid; Cholic Acids; Deoxycholic Acid; Feces; Hypercholesterolemia; Lithocholic Acid; Liver; Male; Rats; Rats, Inbred Strains; Steroid Hydroxylases; Weaning

1990
Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Artery, 1990, Volume: 17, Issue:5

    Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Coturnix; Diet, Atherogenic; Disease Models, Animal; Hypercholesterolemia; Male; Polyamines; Therapeutic Equivalency

1990
Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.
    European journal of clinical investigation, 1989, Volume: 19, Issue:5

    Topics: Adult; Aged; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Lovastatin; Male; Middle Aged; Triglycerides

1989
Controlling cholesterol with drugs.
    The American journal of nursing, 1989, Volume: 89, Issue:12

    Topics: Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lovastatin; Niacin

1989
[Diets and drugs to lower blood cholesterol].
    La Revue du praticien, 1989, Apr-20, Volume: 39, Issue:12

    Topics: Cholesterol; Cholestyramine Resin; Dietary Fats; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia

1989
The purity of cholestyramine resin.
    JAMA, 1989, Dec-08, Volume: 262, Issue:22

    Topics: Adult; Child; Cholestyramine Resin; Drug Contamination; Humans; Hypercholesterolemia; Male; Middle Aged

1989
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    The American journal of cardiology, 1987, May-29, Volume: 59, Issue:14

    Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Disease Models, Animal; Doxazosin; Female; Hypercholesterolemia; Lipoproteins; Male; Mice; Mice, Inbred Strains; Prazosin

1987
[Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Nederlands tijdschrift voor geneeskunde, 1989, Feb-18, Volume: 133, Issue:7

    Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin

1989
[Physiology and pathophysiology of lipoprotein metabolism--relation to hyperlipemias and arteriosclerosis].
    Der Internist, 1985, Volume: 26, Issue:7

    Topics: Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Enterohepatic Circulation; Homeostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Liver; Muscle, Smooth, Vascular; Receptors, Cell Surface; Receptors, Lipoprotein; Triglycerides

1985
Hypercholesterolemia: new values, new strategies.
    Hospital practice (Office ed.), 1986, Jan-30, Volume: 21, Issue:1A

    Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin

1986
Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.
    JAMA, 1987, Nov-06, Volume: 258, Issue:17

    Topics: Adult; Aged; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Life Expectancy; Male; Middle Aged

1987
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
    JAMA, 1988, Apr-15, Volume: 259, Issue:15

    Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking

1988
Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapy.
    Journal of lipid research, 1988, Volume: 29, Issue:7

    Topics: Bile; Cholestyramine Resin; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Intestinal Mucosa; Jejunum; Lovastatin; Male; Middle Aged

1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
    Archives of internal medicine, 1988, Volume: 148, Issue:1

    Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors

1988
Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:12

    Topics: Animals; Anticholesteremic Agents; Charcoal; Cholestyramine Resin; Deoxycholic Acid; Hypercholesterolemia; In Vitro Techniques; Rabbits

1987
Current pharmacologic treatment of elevated serum cholesterol.
    Circulation, 1987, Volume: 76, Issue:3

    Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides

1987
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    The American journal of medicine, 1987, Volume: 83, Issue:2

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Polyamines; Time Factors; Triglycerides

1987
Comparison of six pharmacologic regimens for hypercholesterolemia.
    The American journal of cardiology, 1987, Apr-01, Volume: 59, Issue:8

    Topics: Adult; Aged; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Retrospective Studies

1987
[Drugs in hyperlipidemia].
    Nederlands tijdschrift voor geneeskunde, 1987, Sep-05, Volume: 131, Issue:36

    Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin

1987
Paediatric guidelines for lipid reduction.
    European heart journal, 1987, Volume: 8 Suppl E

    Topics: Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Reference Values

1987
[Cholesterol consensus in The Netherlands].
    Nederlands tijdschrift voor geneeskunde, 1987, Oct-24, Volume: 131, Issue:43

    Topics: Cholesterol, Dietary; Cholestyramine Resin; Humans; Hypercholesterolemia

1987
Lovastatin: cholesterol-lowering agent.
    American family physician, 1987, Volume: 36, Issue:6

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Humans; Hypercholesterolemia; Lovastatin; Probucol

1987
The effect of cholestyramine on apolipoproteins in cholesterol-fed rabbits.
    Artery, 1986, Volume: 13, Issue:4

    Topics: Animals; Apolipoproteins; Apolipoproteins B; Apolipoproteins E; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Electrophoresis, Polyacrylamide Gel; Hypercholesterolemia; Male; Rabbits

1986
Interactions of the major risk factors for coronary heart disease.
    The American journal of medicine, 1986, Feb-14, Volume: 80, Issue:2A

    Topics: Age Factors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Diet, Reducing; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertension; Male; Physical Exertion; Risk; Smoking; Sodium Chloride

1986
Preventing myocardial infarction: cholestyramine (Questran) and other hypolipidemics.
    The Nurse practitioner, 1986, Volume: 11, Issue:3

    Topics: Cholestyramine Resin; Constipation; Humans; Hypercholesterolemia; Hypolipidemic Agents; Kinetics; Myocardial Infarction; Nurse Practitioners; Patient Education as Topic

1986
Cholestyramine treatment during pregnancy in the rat results in hypercholesterolemia.
    Atherosclerosis, 1985, Volume: 57, Issue:2-3

    Topics: Animals; Bile Acids and Salts; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Feces; Female; Gestational Age; Hypercholesterolemia; Liver; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred Strains; Steroids

1985
Treatment of young rats with cholestyramine or a hypercholesterolemic diet does not influence the response of serum cholesterol to dietary cholesterol in later life.
    Atherosclerosis, 1985, Volume: 58, Issue:1-3

    Topics: Age Factors; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Female; Hypercholesterolemia; Liver; Rats; Rats, Inbred Strains

1985
[Hyperlipidemia and coronary disease].
    Revue d'epidemiologie et de sante publique, 1985, Volume: 33, Issue:4-5

    Topics: Adult; Cholestyramine Resin; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipidemias; Japan; Male; Middle Aged; Risk; United States

1985
Portacaval shunt in hyperlipoproteinaemia.
    Lancet (London, England), 1973, Oct-27, Volume: 2, Issue:7835

    Topics: Acute Disease; Angina Pectoris; Aortic Valve Stenosis; Biopsy; Child; Child, Preschool; Cholestyramine Resin; Diet Therapy; Female; Follow-Up Studies; Heart Failure; Homozygote; Humans; Hypercholesterolemia; Infant; Lipoproteins; Lipoproteins, LDL; Liver; Microscopy, Electron; Myocardial Infarction; Portacaval Shunt, Surgical; Triglycerides; Xanthogranuloma, Juvenile

1973
Letter: Portacaval shunt in familial hypercholesterolaemia.
    Lancet (London, England), 1974, Nov-23, Volume: 2, Issue:7891

    Topics: Cholestyramine Resin; Homozygote; Humans; Hypercholesterolemia; Nicotinic Acids; Portacaval Shunt, Surgical

1974
Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients.
    Nutrition and metabolism, 1973, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Blood Protein Disorders; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Female; Homozygote; Humans; Hypercholesterolemia; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Xanthomatosis

1973
[On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
    Casopis lekaru ceskych, 1973, Dec-07, Volume: 112, Issue:49

    Topics: Adult; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male

1973
Homozygous type II hyperlipoproteinemia treatment. Partial ileal bypass in two children.
    JAMA, 1974, Mar-11, Volume: 227, Issue:10

    Topics: Adult; Child; Cholesterol; Cholestyramine Resin; Diet; Female; Follow-Up Studies; Homozygote; Humans; Hypercholesterolemia; Ileum; Lipoproteins, LDL; Male; Pedigree; Phenotype; Resins, Plant; Xanthogranuloma, Juvenile

1974
Hyperlipidemia and coronary artery disease. Prinicples of diet and drug treatment.
    The Medical clinics of North America, 1974, Volume: 58, Issue:2

    Topics: Amino Alcohols; Arteriosclerosis; Carbohydrates; Cholestyramine Resin; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Polymers; Triglycerides

1974
Cholestyramine for elevated serum cholesterol.
    The Medical letter on drugs and therapeutics, 1974, Apr-12, Volume: 16, Issue:8

    Topics: Blood Protein Disorders; Celiac Disease; Cholestyramine Resin; Constipation; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins, LDL; Triglycerides

1974
Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974, Jan-26, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Age Factors; Blood Protein Electrophoresis; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diet Therapy; Female; Homozygote; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pedigree

1974
Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Pediatrics, 1974, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Blood Protein Disorders; Child; Child, Preschool; Cholestyramine Resin; Diet Therapy; Dietary Fats; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Resins, Plant; Vitamin A; Vitamin E

1974
[Treatment of hyperlipoproteinemias (author's transl)].
    Giornale italiano di cardiologia, 1974, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin

1974
Pseudohomozygous type II hyperlipoproteinemia.
    The Journal of pediatrics, 1974, Volume: 85, Issue:5

    Topics: Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diagnosis, Differential; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Pedigree; Triglycerides

1974
Hypercholesterolemia and hypertriglyceridemia in children.
    Preventive medicine, 1974, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Arteriosclerosis; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diet, Reducing; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Lipids; Lipoproteins; Myocardial Infarction; Phenotype; Triglycerides

1974
An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate.
    Medecine & chirurgie digestives, 1972, Volume: 1, Issue:5

    Topics: Chlorides; Cholestyramine Resin; Clofibrate; Drug Synergism; Humans; Hypercholesterolemia; Ion Exchange Resins; Long-Term Care

1972
Physiologic and clinical significance of ileal resection.
    Surgery annual, 1972, Volume: 4

    Topics: Bile Acids and Salts; Biotransformation; Celiac Disease; Cholelithiasis; Cholestyramine Resin; Diarrhea; Humans; Hypercholesterolemia; Ileum; Intestinal Diseases; Kidney Calculi; Lipid Metabolism; Malabsorption Syndromes; Obesity; Postoperative Complications; Vitamin B 12; Water-Electrolyte Balance

1972
The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
    Advances in experimental medicine and biology, 1972, Volume: 26, Issue:0

    Topics: Anion Exchange Resins; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Dietary Fats; Diethylamines; Drug Synergism; Fatty Acids, Unsaturated; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver; Models, Biological; Time Factors; Triglycerides

1972
An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Angiology, 1973, Volume: 24, Issue:1

    Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrans; Drug Synergism; Ethylamines; Humans; Hypercholesterolemia; Ion Exchange Resins; Lipoproteins; Time Factors; Triglycerides

1973
[Hypolipemic agents].
    Minerva medica, 1973, Apr-14, Volume: 64, Issue:24

    Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipid Metabolism; Lipids; Neomycin; Nicotinic Acids; Thyroid Hormones; Triglycerides

1973
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Kardiologiia, 1973, Volume: 13, Issue:3

    Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Mobilization; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Phospholipids; Sitosterols; Triglycerides

1973
Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
    Journal of lipid research, 1974, Volume: 15, Issue:4

    Topics: Animals; Bile Acids and Salts; Body Weight; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Feces; Hypercholesterolemia; Intestines; Male; Swine

1974
Effects of an anion exchange resin (cholestyramine) on atherogenesis in rhesus monkeys.
    The American surgeon, 1969, Volume: 35, Issue:12

    Topics: Animals; Arteriosclerosis; Cholestyramine Resin; Diet, Atherogenic; Haplorhini; Hypercholesterolemia; Iodine Isotopes; Time Factors

1969
Comparison of the protective effects of cholestyramine and ileal bypass in rhesus monkeys on an atherogenic regimen.
    Surgical forum, 1969, Volume: 20

    Topics: Animals; Arteriosclerosis; Cholestyramine Resin; Diet, Atherogenic; Haplorhini; Hypercholesterolemia; Ileum; Methods

1969
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
    Geriatrics, 1972, Volume: 27, Issue:5

    Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Exercise Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Neomycin; Nicotinic Acids; Nitrates; Stress, Physiological; Thyroxine; Triglycerides

1972
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
    Journal of lipid research, 1972, Volume: 13, Issue:4

    Topics: Adult; Aged; Bile; Bile Acids and Salts; Carbon Isotopes; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fats; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Mucosa; Male; Middle Aged; Steroids; Triglycerides; Xanthomatosis

1972
[Therapy of primary hyperlipidemias].
    Minerva medica, 1972, Aug-18, Volume: 63, Issue:58

    Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids

1972
Drug treatment of hyperlipidemia.
    Journal of the Iowa Medical Society, 1972, Volume: 62, Issue:10

    Topics: Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Triglycerides

1972
[Hypercholesterinemia: treatment with Colestyramin].
    Fortschritte der Medizin, 1972, Jun-15, Volume: 90, Issue:18

    Topics: Bile Acids and Salts; Binding Sites; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Iron; Male; Middle Aged; Water-Electrolyte Balance

1972
Serum lipid precursors of coronary heart disease.
    Human pathology, 1971, Volume: 2, Issue:1

    Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholesterol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coronary Disease; Diet Therapy; Epidemiologic Methods; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Phospholipids; Prognosis; Sex Factors; Thyroxine; Triglycerides

1971
Classification of hyperlipidaemias.
    Proceedings of the Royal Society of Medicine, 1971, Volume: 64, Issue:9

    Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides

1971
Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions.
    Annals of clinical research, 1971, Volume: 3, Issue:5

    Topics: Carbon Isotopes; Cholesterol; Cholestyramine Resin; Chromatography, Gas; Fasting; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Ileum; Lipoproteins; Obesity; Steroids; Sterols; Triglycerides; Tritium; Ultracentrifugation

1971
Cholesterol metabolism in patients with coronary heart disease.
    Annals of clinical research, 1971, Volume: 3, Issue:6

    Topics: Adult; Bile Acids and Salts; Body Weight; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Coronary Disease; Electrocardiography; Feces; Female; Glucose Tolerance Test; Glycerides; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged; Sterols; Triglycerides; Tritium

1971
[Diagnosis and therapy of familial hyper- -lipoproteinemia (familial hypercholesterolemia or familial hyperlipoproteinemia of type II)].
    Recenti progressi in medicina, 1971, Volume: 51, Issue:5

    Topics: Adolescent; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Thyroid Hormones

1971
Control of biochemical precursors of coronary heart disease.
    Geriatrics, 1969, Volume: 24, Issue:12

    Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Triglycerides

1969
The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.
    Clinical science, 1969, Volume: 37, Issue:2

    Topics: Adolescent; Adult; Bile Acids and Salts; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Feces; Female; Humans; Hypercholesterolemia; Injections, Intravenous; Male; Skin; Skin Manifestations; Steroids

1969
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
    Therapeutische Umschau. Revue therapeutique, 1970, Volume: 27, Issue:3

    Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Sterols; Thyroxine

1970
Treatment of hyperlipidemic states.
    The Medical clinics of North America, 1970, Volume: 54, Issue:6

    Topics: Adult; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Thyroid Hormones; Thyroxine; Triglycerides

1970
Detection of changes in human cholesterol metabolism.
    Annals of clinical research, 1970, Volume: 2, Issue:4

    Topics: Bile Acids and Salts; Carbon Isotopes; Cholestanes; Cholesterol; Cholestyramine Resin; Deuterium; Fasting; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Malabsorption Syndromes; Male; Obesity; Sex Factors; Sterols; Triglycerides; Tritium

1970
Diet and drug therapy for hyperlipoproteinemia.
    Medical times, 1971, Volume: 99, Issue:8

    Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Propionates; Thyroxine; Triglycerides

1971
[Therapy of primary hyperlipemia].
    Deutsche medizinische Wochenschrift (1946), 1971, May-07, Volume: 96, Issue:19

    Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Diet, Reducing; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Nicotinic Acids

1971
Control of diarrhea by cholestyramine administration.
    The American journal of the medical sciences, 1968, Volume: 255

    Topics: Adolescent; Adult; Bile Acids and Salts; Biological Transport; Cholestyramine Resin; Colostomy; Diarrhea; Female; Gastrointestinal Motility; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Male

1968
Cholestyramine and hypercholesterolaemia.
    British medical journal, 1968, Mar-09, Volume: 1, Issue:5592

    Topics: Cholestyramine Resin; Humans; Hypercholesterolemia

1968
Treatment of hypercholesterolemia. Combined dietary, surgical, and bile salt-binding resin therapy.
    Archives of surgery (Chicago, Ill. : 1960), 1968, Volume: 97, Issue:2

    Topics: Adolescent; Adult; Cecum; Cholesterol; Cholestyramine Resin; Diet Therapy; Humans; Hypercholesterolemia; Ileum; Middle Aged

1968
Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient.
    The Journal of clinical investigation, 1968, Volume: 47, Issue:7

    Topics: Bile Acids and Salts; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Feces; Humans; Hypercholesterolemia; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Sterols

1968
Hypolipidemic effect of polyvinylpyrrolidone in man.
    Circulation, 1968, Volume: 38, Issue:4

    Topics: Adult; Blood Glucose; Blood Pressure; Blood Proteins; Body Weight; Cholesterol; Cholestyramine Resin; Dextrans; Female; Follow-Up Studies; Hematocrit; Humans; Hypercholesterolemia; Hyperlipidemias; Infusions, Parenteral; Isotonic Solutions; Male; Middle Aged; Plasma Substitutes; Plasma Volume; Potassium; Povidone; Sodium; Triglycerides

1968
Response of hyperlipoproteinemia to cholestyramine resin.
    JAMA, 1968, Jun-24, Volume: 204, Issue:13

    Topics: Adult; Blood Protein Electrophoresis; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Triglycerides

1968
Cholestyramine.
    Drug and therapeutics bulletin, 1968, Oct-11, Volume: 6, Issue:21

    Topics: Biliary Tract Diseases; Cholestyramine Resin; Diarrhea; Humans; Hypercholesterolemia; Pruritus

1968
[Therapy of primary hyperlipemias].
    Deutsche medizinische Wochenschrift (1946), 1969, Feb-14, Volume: 94, Issue:7

    Topics: Androsterone; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Diet Therapy; Glycerides; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Smoking

1969
New drugs for the treatment of hypercholesterolemia.
    Virginia medical monthly, 1969, Volume: 96, Issue:1

    Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia

1969
[Basic treatment of coronary atherosclerosis].
    La Presse medicale, 1969, Jun-07, Volume: 77, Issue:28

    Topics: Activities of Daily Living; Angina Pectoris; Anticoagulants; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet, Atherogenic; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fats, Unsaturated; Female; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Nicotinic Acids; Smoking; Triglycerides; Uric Acid

1969
Treatment of hypercholesteremia and hypertriglyceridemia.
    JAMA, 1969, Jan-27, Volume: 207, Issue:4

    Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides

1969
Treatment of hypercholesteremia and hypertriglyceridemia.
    JAMA, 1969, Jan-27, Volume: 207, Issue:4

    Topics: Cholestyramine Resin; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides

1969
The effect of hypocholesteremic agents on the skin.
    Geriatrics, 1966, Volume: 21, Issue:10

    Topics: Acanthosis Nigricans; Alopecia; Anticholesteremic Agents; Arteriosclerosis; Cataract; Cholestyramine Resin; Hair; Humans; Hypercholesterolemia; Ichthyosis; Pruritus; Psoriasis; Skin Diseases; Xanthomatosis

1966